ABC Laboratories - Services ABC Laboratories - Resources ABC Laboratories - Careers ABC Laboratories - News ABC Laboratories - Contact Us
ABClabs - Slogan Area
Pharmaceutical Development Agro/Chemical Testing About ABC
Pharmaceutical / Animal Health
Environmental Assessments for Human Pharmaceuticals and Animal Health Products

ABC Laboratories draws on 40 years of analytical expertise identifying and quantifying test substances in soil, water, complex media and biological tissues to deliver a complete package of environmental assessment tests to our pharmaceutical and animal health customers. ABC offers the full array of required product chemistry, ecotoxicology, environmental fate and metabolism studies. ABC also performs radiolabeling synthesis to support specific study requirements. Our laboratories are well-equipped with the latest mass spectrometry instrumentation to ensure highly sensitive, robust methods and rapid, reliable test results.

The U.S. Food and Drug Administration (FDA) requires that an environmental assessment accompany any New Drug Application (NDA) or Animal NDA for a drug with an expected environmental concentration greater than one part per billion (ppb), as well as those known to cause adverse ecotoxicological effects at lower concentrations. Through established relationships with consulting firms specializing in NDA/NADA risk assessments and registration submissions, ABC will guide our customers through regulatory requirements and prepare the necessary EA summary report for submission to the FDA. Additionally, ABC conducts environmental risk assessments (ERAs) under European Union Directive 200/83/EC. ERAs are required if the Predicted Environmental Concentration (PEC) is >0.01 ppb in water or ≥10 ppb in soil, or if effects are suggested at lower concentrations based on related substances or biological studies. Environmental risk assessments are required for all new animal health drugs.


Physical-Chemical Properties
  • Water Solubility (FDA TAD 3.01 / OECD 105)
  • n-Octanol/Water Partition (FDA TAD 3.02 / OECD 107)
  • Vapor Pressure (FDA TAD 3.03 / OECD 104)
  • Dissociation Constant (FDA TAD 3.04 / OECD 112)
  • Ultraviolet-Visible Adsorption Spectrum (FDA TAD 3.05 / OECD 101)
  • Melting Temperature (FDA TAD 3.06 / OECD 102)
  • Density and Relative Density (FDA TAD 3.07 / OECD 109)

Environmental Fate
  • Sorption/Desorption (FDA TAD 3.08 / OECD 106)
  • Hydrolysis (FDA TAD 3.09 / OECD 111)
  • Photodegradation in Water (FDA TAD 3.10 / OECD Monograph 61)
  • Aerobic Biodegradation in Water (FDA TAD 3.11 / OECD 301 and 302 Series)
  • Aerobic Biodegradation in Soil or Sediment (FDA TAD 3.12 / OECD 307 or OECD 308)

Environmental Effects
  • Algal Toxicity (FDA TAD 4.01 / OECD 201)
  • Microbial Growth Inhibition or Activated Sludge Respiration Inhibition (FDA TAD 4.02 / OECD 209)
  • Seed Germination & Root Elongation (FDA TAD 4.06 / OECD 208)
  • Seedling Growth (FDA TAD 4.07 / OECD 208)
  • Daphnia magna Acute Toxicity (FDA TAD 4.08 / OECD 202)
  • Daphnia magna Chronic Toxicity (FDA TAD 4.09 / OECD 211)
  • Hyalella azteca Acute Toxicity (FDA TAD 4.09)
  • Freshwater Fish Acute Toxicity (FDA TAD 4.11 / OECD 203)
  • Earthworm Subacute Toxicity (FDA TAD 4.11 / OECD 203)
  • Freshwater Fish Early Life-Stage Toxicity (OECD 210)
  • Earthworm Reproduction Toxicity (OECD 222)
  • Soil Arthropod Toxicity (ISO 11270)
  • Soil Microorganisms: Nitrogen or Carbon Transformation (OECD 216 or 217)
RIGHTSIDE GRAPHIC OR PHOTO
abclabs Equipped with the latest mass spectrometers that offer sensitivity and speed, our scientists apply extensive methods development and analytical chemistry experience to deliver the broad array of environmental assessment data now required by regulatory agencies.
ABC labs - Virtual Tour - Chemical Facility